These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

475 related articles for article (PubMed ID: 20413641)

  • 1. Radioprotectors and mitigators of radiation-induced normal tissue injury.
    Citrin D; Cotrim AP; Hyodo F; Baum BJ; Krishna MC; Mitchell JB
    Oncologist; 2010; 15(4):360-71. PubMed ID: 20413641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radioprotective agents for radiation therapy: future trends.
    Johnke RM; Sattler JA; Allison RR
    Future Oncol; 2014 Dec; 10(15):2345-57. PubMed ID: 25525844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of drugs in the prevention and amelioration of radiation induced toxic effects.
    Patyar RR; Patyar S
    Eur J Pharmacol; 2018 Jan; 819():207-216. PubMed ID: 29221951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiosensitizers, radioprotectors, and radiation mitigators.
    Raviraj J; Bokkasam VK; Kumar VS; Reddy US; Suman V
    Indian J Dent Res; 2014; 25(1):83-90. PubMed ID: 24748306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radioprotectors - the evergreen topic.
    Kuntić VS; Stanković MB; Vujić ZB; Brborić JS; Uskoković-Marković SM
    Chem Biodivers; 2013 Oct; 10(10):1791-803. PubMed ID: 24130023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological strategies to spare normal tissues from radiation damage: useless or overlooked therapeutics?
    Bourgier C; Levy A; Vozenin MC; Deutsch E
    Cancer Metastasis Rev; 2012 Dec; 31(3-4):699-712. PubMed ID: 22706781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of amifostine as a radioprotector.
    Wasserman TH; Brizel DM
    Oncology (Williston Park); 2001 Oct; 15(10):1349-54; discussion 1357-60. PubMed ID: 11702962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radioprotection of normal tissue cells.
    Maier P; Wenz F; Herskind C
    Strahlenther Onkol; 2014 Aug; 190(8):745-52. PubMed ID: 24638269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacologic approaches to radiation protection.
    Brizel DM
    J Clin Oncol; 2007 Sep; 25(26):4084-9. PubMed ID: 17827457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiation Protection and Mitigation by Natural Antioxidants and Flavonoids: Implications to Radiotherapy and Radiation Disasters.
    Yahyapour R; Shabeeb D; Cheki M; Musa AE; Farhood B; Rezaeyan A; Amini P; Fallah H; Najafi M
    Curr Mol Pharmacol; 2018; 11(4):285-304. PubMed ID: 29921213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does amifostine have a role in chemoradiation treatment?
    Brizel DM; Overgaard J
    Lancet Oncol; 2003 Jun; 4(6):378-81. PubMed ID: 12788413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radioprotective countermeasures for radiation injury (Review).
    Liu L; Liang Z; Ma S; Li L; Liu X
    Mol Med Rep; 2023 Mar; 27(3):. PubMed ID: 36799170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radioprotectors.org: an open database of known and predicted radioprotectors.
    Aliper AM; Bozdaganyan ME; Sarkisova VA; Veviorsky AP; Ozerov IV; Orekhov PS; Korzinkin MB; Moskalev A; Zhavoronkov A; Osipov AN
    Aging (Albany NY); 2020 Aug; 12(15):15741-15755. PubMed ID: 32805729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review of compounds that exhibit radioprotective and/or mitigatory effects after application of diagnostic or therapeutic ionizing radiation.
    Zivkovic Radojevic M; Milosavljevic N; Miladinovic TB; Janković S; Folic M
    Int J Radiat Biol; 2023; 99(4):594-603. PubMed ID: 35930681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacologic normal tissue protection in clinical radiation oncology: focus on amifostine.
    Mell LK; Movsas B
    Expert Opin Drug Metab Toxicol; 2008 Oct; 4(10):1341-50. PubMed ID: 18798703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreasing the adverse effects of cancer therapy: an NCI Workshop on the preclinical development of radiation injury mitigators/protectors.
    Ryan JL; Krishnan S; Movsas B; Coleman CN; Vikram B; Yoo SS
    Radiat Res; 2011 Nov; 176(5):688-91. PubMed ID: 21883022
    [No Abstract]   [Full Text] [Related]  

  • 17. Protection of normal tissue from the cytotoxic effects of chemotherapy and radiation by amifostine: clinical experiences.
    Capizzi RL; Oster W
    Eur J Cancer; 1995; 31A Suppl 1():S8-13. PubMed ID: 7577096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacology of natural radioprotectors.
    Mun GI; Kim S; Choi E; Kim CS; Lee YS
    Arch Pharm Res; 2018 Nov; 41(11):1033-1050. PubMed ID: 30361949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacologic approaches to protection against radiation-induced lethality and other damage.
    Weiss JF
    Environ Health Perspect; 1997 Dec; 105 Suppl 6(Suppl 6):1473-8. PubMed ID: 9467066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiotherapeutic studies with amifostine (Ethyol).
    Wasserman TH
    Semin Oncol; 1994 Oct; 21(5 Suppl 11):21-5. PubMed ID: 7973775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.